Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana P Gonzalez-Rodriguez

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|October 2, 2019
NK Cells in the Treatment of Hematological MalignanciesAna P Gonzalez-Rodriguez, Mónica Villa-Álvarez, Christian Sordo-Bahamonde, et al.
Cancers|January 2, 2019
NK Cell-Based Immunotherapy in Cancer MetastasisSeila Lorenzo-Herrero, Alejandro López-Soto, Christian Sordo-Bahamonde, et al.
Cancers|April 30, 2021
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic LeukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.
Cancers|June 10, 2023
Chemo-Immunotherapy: A New Trend in Cancer TreatmentChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.
Oncoimmunology|November 11, 2017
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemiaMónica Villa-Álvarez, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.
Frontiers in Immunology|January 9, 2019
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic LeukemiaMónica Villa-Álvarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, et al.
Journal of Clinical Medicine|November 20, 2020
Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive ProgressionAna P Gonzalez-Rodriguez, Angel R Payer, Juan J Menendez-Suarez, et al.
Leukemia & Lymphoma|September 18, 2010
Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemiaAna P Gonzalez-Rodriguez, Juan Contesti, Leticia Huergo-Zapico, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2023
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Alejandra Martínez-Pérez, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2012
Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA sheddingLeticia Huergo-Zapico, Ana P Gonzalez-Rodriguez, Juan Contesti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|October 2, 2019
NK Cells in the Treatment of Hematological MalignanciesAna P Gonzalez-Rodriguez, Mónica Villa-Álvarez, Christian Sordo-Bahamonde, et al.
Cancers|January 2, 2019
NK Cell-Based Immunotherapy in Cancer MetastasisSeila Lorenzo-Herrero, Alejandro López-Soto, Christian Sordo-Bahamonde, et al.
Cancers|April 30, 2021
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic LeukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.
Cancers|June 10, 2023
Chemo-Immunotherapy: A New Trend in Cancer TreatmentChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.
Oncoimmunology|November 11, 2017
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemiaMónica Villa-Álvarez, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.
Frontiers in Immunology|January 9, 2019
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic LeukemiaMónica Villa-Álvarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, et al.
Journal of Clinical Medicine|November 20, 2020
Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive ProgressionAna P Gonzalez-Rodriguez, Angel R Payer, Juan J Menendez-Suarez, et al.
Leukemia & Lymphoma|September 18, 2010
Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemiaAna P Gonzalez-Rodriguez, Juan Contesti, Leticia Huergo-Zapico, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2023
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Alejandra Martínez-Pérez, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2012
Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA sheddingLeticia Huergo-Zapico, Ana P Gonzalez-Rodriguez, Juan Contesti, et al.
Pageof 2